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low fever, and dyspnea for 1 month, associated with
decreased appetite and weight loss. She had previously
been healthy. Her mother’s brother had died from
hepatocarcinoma.
Physical examination demonstrated inaudible breath
sounds in the right thorax but no other remarkable findings.
A chest X-ray showed a large right pleural effusion. Pleu-
rocentesis was performed, and testing the pleural effusion
showed inflammatory change. No mycobacteria or tumor
cells could be found. A diagnosis of tuberculous pleuritis
was first considered, and the patient was put on antitu-
berculosis therapy for 2 months. However, there was no
reduction in the effusion.
A computed tomography (CT) scan of the chest then
showed diffuse irregular pleural thickening (Fig. 1A), and
video-assisted thoracoscopic biopsy revealed diffuse
nodular lesions on the pleura. Microscopically, the tumor
was composed of distinctly outlined tumor cell nests,
clusters, and trabeculae of small round to oval cells withThe authors have no conflicts of interest relevant to this article.
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tumor cells were surrounded by a dense desmoplastic
fibrous stroma (Fig. 1B,C). Immunohistochemical findings
were: Cytokeratin (CK)(e), Vimentin (Vim)(þþ), Leuco-
cyte common antigen (LCA)(e), CD20(e), Neuron Specific
Enolase (NSE) (), Synaptophysin (Syn) (), Chromogra-
nin-A (Chr-A)(e), CD34(e), Carcinoembryonic Antigen
(CEA)(e), Factor VIII-related antigen (VⅢfactor)(e),
Desmin(þ), S100(þ), Epithelial Membrane Antigen
(EMA)(e), Smooth Muscle Actin (SMA)(e). Gene analysis
identified the gene fusion of the Ewing’s sarcoma gene
(EWS ) and Wilms’ tumor gene (WT1), which confirmed the
diagnosis of desmoplastic small round cell tumor (DSRCT).
Abdominal and pelvic CT scanning showed no neoplasms.
The patient received chemotherapy in line with the P6
protocol.
After chemotherapy, the pleural effusion came under
control and complete remission of the pleural thickening
was observed. However, a recurrence presented 4 months
later with pleural effusion and ascites. The patient
refused further therapy and was discharged. The survival
time from presentation was 22 months.
DSRCT was first reported in 1989 by Gerald et al.1 It is
characterized by aggressive behavior and a poor prognosis.1
DSRCT usually presents in adolescents and young adults.
The abdomen and pelvis are the sites most likely to be
involved; DSRCT of the pleura is extremely rare.& Formosan Medical Association. All rights reserved.
Figure 1 (A) Chest computed tomography scan showing a large amount of pleural effusion and diffuse irregular pleural thick-
ening. (B) Nests of small round cells embedded in a dense desmoplastic fibrous stroma. H&E stain, 200. (C) Nuclear features of the
tumor cells. H&E stain, 400.
Desmoplastic small round cell tumor of the pleura 61Due to the rarity of DSRCT and the absence of special
clinical manifestations, clinicians may overlook the diag-
nosis of this disease, especially when it arises in the thorax.
The main manifestations are chest pain and respiratory
symptoms.2 In this case, clinicians first considered tuber-
culous pleuritis based on the clinical findings and relatively
high prevalence of tuberculosis in China.
This case indicates that early tissue biopsy is essential
when encountering a pleural effusion of unknown cause or
one that does not respond to therapy. Needle core biopsy is
an effective tool, but has limitations in terms of identifying
DSRCT.3 Due to the diverse differentiation of DSRCT,1
comprehensive histopathological diagnosis should be
based on an adequate specimen.4 Surgical biopsy is superior
to needle core biopsy to obtain large samples of tissue.3 If
DSRCT is suspected, surgical biopsy is the first treatment
option.
Although a multidisciplinary approach has been applied
to DSRCT, survival has not been improved significantly.
The tumor may respond to chemotherapy, but
progression-free survival is usually short.5 The P6 protocol
combined with aggressive surgery and radiotherapy isconsidered to be efficient in prolonging the progression-
free survival.5
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